##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 68 Download : 58

##plugins.themes.academic_pro.article.main##

Abstract

The 2019 Chinese flu pandemic has been traced back to a novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The 2019 coronavirus illness has been designated as COVID-19. Methods two hundred covid-19 cases were validated by RT PCR in a multi-center, prospective, observational and interventional research. At admission, all patients had their oxygen levels, inflammation marker D-Dimer, and chest HRCT taken. primary emphasis and subsequent dialogue. Age, gender, comorbidities, BIPAP/NIV use, and outcome were recorded, as was the presence or absence of lung fibrosis. Medical professionals can rule out DVT and PTE in some individuals with the help of CT pulmonary angiography and lower limb venous doppler. For statistical purposes, the Chi-square test is applied

Keywords

D-dimer COVID-19 out-hospitalized patients biomarker

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Dr. Mohammed Kareem Ahmed, Dr. Mohammed Adnan Khaleefah, Dr. Mohamed Ismael Jawameer, & Dr. Duraid Khalil Ibrahim. (2023). D-dimer as Sensitive parameters in COVID-19 (Study of 200 patients). Texas Journal of Medical Science, 27, 39–46. https://doi.org/10.62480/tjms.2023.vol27.pp39-46
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Scottish Intercollegiate Guidelines Network. Implementation Support. Implementation Support [Available from: https://www.sign.ac.uk/implementation-support.html] accessed 15 July 2019.
  2. World Health Organisation. Coronavirus disease (COVID-2019) situation reports 2020 [Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation- reports/] Accessed 2020 Jun 1.
  3. Centers for Disease Control and Prevention. Human Coronavirus Types 2020 [Available from: https://www.cdc.gov/coronavirus/types.html] Accessed 2020 Jun 1.
  4. Walker KF, O’Donoghue K, Grace N, et al. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis. BJOG 2020;127(11):1324-36.
  5. Salvatore CM, Han JY, Acker KP, et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health 2020;4(10):721-27.
  6. Dumitriu D, Emeruwa UN, Hanft E. Outcomes of neonates born to mothers with severe acute respiratory syndrome coronavirus 2 infection at a large medical center in NewYork City. JAMA Pediatr. Published online October 12, 2020.
  7. Mejia Jimenez, Salvador Lopez R, Garcia Rosas E, et al.; Spanish Obstetric Emergency Group. Umbilical cord clamping and skin-to-skin contact in deliveries from women positive for SARS-CoV-2: a prospective observational study. BJOG 2020 http://dx.doi.org/10.1111/1471- 0528.16597.
  8. Coronavirus disease (COVID-19) weekly epidemiological update and weekly operational update. Available at: https:// www.who.int/emergenc aies/diseases/novel-coronavirus- 2019/situation-reports. Accessed Dec 24, 2021.
  9. Lippi G, Plebani M. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med 2020;58:1063–9. [CrossRef ]
  10. Bohn MK, Lippi G, Horvath A, Sethi S, Koch D, Ferrari M, et al. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clin Chem Lab Med 2020;58:1037–52. [CrossRef ]
  11. Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet. 2020 Mar 28;395(10229):1014-1015. doi: 10.1016/S0140-6736(20)30633-4. Epub 2020 Mar 17.
  12. PMID: 32197108; PMCID: PMC7138151. [CrossRef ]
  13. Dempfle Ce. Validation, calibration, and specificity of quantitative D-dimer assays. Semin Vasc Med 2005;5:315–20.
  14. Bockenstedt P. D-dimer in venous thromboembolism. N Engl J Med 2003;349:1203–4. [CrossRef ]
  15. Kabrhel C, Mark Courtney D, Camargo CA, Plewa MC, Nordenholz KE, Moore CL, et al. Factors associated with positive Ddimer results in patients evaluated for pulmonary embolism.
  16. Acad Emerg Med 2010;17:589–97. [CrossRef ]
  17. Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol 2020;7:438–40. [CrossRef ]
  18. Shah S, Shah K, Patel SB, Patel FS, Osman M, Velagapudi P, et al. Elevated D-dimer levels are associated with increased risk of mortality in coronavirus disease 2019: a systematic review and meta-analysis. Cardiol Rev 2020;28:295–302. [CrossRef ]
  19. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020;18:844–7.
  20. Role of 'Serial D-Dimer Level' in predicting Severity and outcome in COVID-19 pneumonia: A Prospective multicentric Observational Study of 1000 cases in Tertiary Care Setting in India, Shital Patil,1 Abhijit Acharya,2 Gajanan Gondhali,3 Ganesh Narwade4.
  21. The Role of D-Dimers in the Initial Evaluation of COVID-19
  22. Liliana Baroiu 1,*, Ana Cristina Lese 2, Ioana Anca Stefanopol 3,*, Alina Iancu
  23. D-Dimer as a Sensitive Biomarker of Survival Rate in Patients with COVID-19, Fadhilatul Hilda1 , Phey Liana2,3 , Awan Nurtjahyo4 , Harun Hudari5.
  24. Elevated D-Dimer and acute pulmonary embolism in COVID-19 patients Dímero-D elevado y tromboembolismo pulmonar agudo en pacientes con COVID-19, Yoselin Dos Santos-Poleo1, Lorenzo Pérez-Sánchez.
  25. D-dimer in COVID-19: A Guide With Pitfalls Roger E. Schutgens, Correspondence: Roger E. Schutgens (e-mail: r.schutgens@umcutrecht.nl)
  26. . D-dimer levels in COVID-19 out-hospitalized patients in Egypt ,Ahmed Abdelhalim Yameny
  27. Society of Pathological Biochemistry and Hematology, Egypt ,Ahmed A. Yameny (Email: dr.ahmedyameny@yahoo.com) Tel: (002)01222708665, (002)0114605175